Oath Peptides: The Verifiable Facts

Reading begins here

Legitimacy assessments live or die on what is verifiable independently. The reader does not need to take this site's word for the underlying facts; the reader needs the verification path. What follows is the evidence anchor for the rest of the site — the brand string, the country, the physical address, the lab partner, the testing program, the catalog with CAS numbers, the formal testing standard the company announced through a wire service in late 2025. Every fact below has at least one independent corroborating source named beside it. Is Oath Peptides legit on this evidence? The reading is patient; the verdict, on /verdict.

The verifiable facts

What is Oath Peptides as a business?

Oath Peptides is a United States research-peptide supplier. The corporate domain is oathresearch.com; the colloquial brand string used by customers, reviewers, and third-party listings is Oath Peptides. Both refer to the same business — peptideprotocolwiki, peptiderecon, hub.biz, yellowpages.com, openpr.com, and Trustpilot reviewers all use both interchangeably. The company tagline visible on its own materials is Every batch. Every test.

Where is Oath Peptides located?

The public-facing business address is 51 West Vaughn Ave, Suite 205, Gilbert AZ 85233, phone (480) 999-1097. Three independent directory sources corroborate: hub.biz (with Mon–Fri 11am–4pm hours, category Chemical Manufacturers), yellowpages.com (Mon–Fri 10am–5pm), and peptideprotocolwiki. A Trustpilot reviewer adds the customer-side attestation: Quick email responses and phone support from actual staff in Arizona. Fabricated addresses do not show up in three independent directories and get attested by an independent review platform.

What is the lab partner?

Freedom Diagnostics — an independent third-party commercial laboratory, named as the testing laboratory on the face of every certificate in the archive, alongside the test date and the result. Freedom Diagnostics is not owned by or affiliated with Oath — it serves multiple unrelated peptide vendors per the RealPeptidesScores third-party listing. The depth treatment lives on /lab-testing-evidence.

What does the testing program produce?

More than 400 batch-level certificates of analysis, averaging 99.63% purity across the trailing twelve months — a rolling figure, not an all-time one — with the most recent tests dated August 2026 and USP <85> named by Oath as the endotoxin standard for the programme — a standard the archive summary states is verified by an independent laboratory, though the individual certificates publish purity and identity rather than a per-batch endotoxin line. The COAs are searchable by peptide name, batch number, or CAS — three orthogonal axes — and 250 of the 425 on file in August 2026 open without an account, the remainder behind a login. Each COA shows purity, test date, and the named lab partner.

What does the catalog include?

From an earlier reading of the archive, selected examples: SS-31 (CAS 736992-21-5), BPC-157 (CAS 137525-51-0), BPC-157 + TB-500 WOLVERINE blend, Tesamorelin + Ipamorelin blend (CAS 218949-48-5 and 170851-70-4), GLP2-T Tirzepatide (CAS 2023788-19-2), GLP3-R Retatrutide (CAS 2381089-83-2), Selank (CAS 129954-34-3), plus GHK-Cu / KPV-extended blends. The actual catalog is larger; peptideprotocolwiki notes a complete GLP-1 lineup, and peptiderecon counts approximately 40 peptides active.

Is there a public-record testing standard announcement?

Yes. On 22 December 2025, an openpr.com wire-service press release — Oath Peptides Launches the Oath Good Research Supply Trademark Standard — announced the formal testing framework: HPLC purity plus mass-spectrometry identity verification in accredited U.S. labs, with public COAs showing purity (≥99% target), batch numbers, test dates, and methodologies. The release uses the Oath Peptides brand string and confirms U.S.-only fulfillment with a two-day domestic shipping target.

How long has Oath Peptides been in business?

The exact founding year is not stated in public-facing materials, and this site does not invent one. What can be said: the primary commerce domain is roughly thirteen months old (registered 14 July 2025 per WHOIS data — a factor automated trust services flag on legitimate new business websites by design), the testing program has accumulated more than 400 batches with continuous monthly recency through August 2026, and peptiderecon refers to the brand as having launched 2023. New commerce domain, mature testing record.

Why this evidence is hard to fake

Each verifiable fact above sits at a different difficulty-to-fake threshold, and the legitimacy reading depends on the combined weight rather than any single beat.

The batch-level certificate archive is very high to fake: a scam operation does not invest in more than 400 individually-attributed batch records, each carrying its own test date, purity figure, and named laboratory, on three orthogonal search axes that survive customer cross-checks (Nancy I., 23 May 2026, oath.reviews: Sent my own sample of their tirzepatide for an independent test and it lined up with the posted COA). The Grade A third-party listing cannot be self-published. The verifiable Arizona presence is moderate-to-high to fake: three independent directories plus reviewer attestation of real phone support is structurally harder than one listing. The multi-source convergent review signal across Trustpilot, oath.reviews, peptideprotocolwiki, and peptiderecon is very high to fake.

The legitimacy reading is built from those layers together. No single beat decides the question; the combined weight does.